MarketPeel
Insider Trading Intelligence
Pricing
…
TC

Thomas Catinazzo

RLAY
CHIEF FINANCIAL OFFICER · RELAY THERAPEUTICS, INC. · CIK 0001818261
FILING MIX · LIFETIME23%/77%
BUYS
23
SELLS
75
TOTAL VALUE
$11.67M
COMPANIES
1
ACTIVE SINCE
Dec 2020
HOLDINGS NOW
223,440
AVG SELL PX
$17.20
TRADE KIND
SHOWING 98 / 98
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
43 backtested trades · 8 horizons · 42 pending
Forward-return performance of every backtestable P/S trade by Thomas Catinazzo, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d43+53.49%-1.33%-0.27%-1.06%-0.46%-0.95
14d43+65.12%-4.95%+0.54%-5.49%-6.71%-3.04
30d43+67.44%-3.75%+1.37%-5.41%-11.00%-1.83
60d43+63.41%-6.64%+1.89%-8.12%-14.41%-2.06
90d43(3 pending)+56.41%-3.35%+2.57%-5.77%-17.59%-1.01
180d43(6 pending)+72.97%-2.86%+5.58%-8.44%-25.59%-1.03
1y43(9 pending)+64.71%+17.70%+13.61%+4.09%-41.83%0.23
2y43(24 pending)+84.21%-40.32%+31.42%-71.75%-91.23%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RLAY · 223,440 shares · as of Jun 22, 2026
0100,583201,166301,748402,331202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 23 buys / 75 sellsCOVERAGE · 23 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
56,323$16.97$955.8K177,461Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
51,560$4.45$229.4K229,021Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
61,563$5.22$321.4K239,024Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
51,560$16.97$875.0K177,461Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
61,563——0Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
56,323$5.04$283.9K233,784Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,717$17.01$301.4K177,461Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
61,563$16.97$1.04M177,461Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
56,323——0Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
51,560——223,440Jun 22, 2026Jun 24, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,717$12.86$227.8K195,178May 14, 2026May 14, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
972$14.79$14.4K212,895Apr 28, 2026Apr 30, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,800$15.00$27.0K213,867Apr 9, 2026Apr 9, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,800——61,563Apr 9, 2026Apr 9, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
1,800$5.22$9.4K215,667Apr 9, 2026Apr 9, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,717$13.01$230.5K213,867Apr 7, 2026Apr 9, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
17,717$10.06$178.2K231,584Mar 9, 2026Mar 11, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,695$8.45$14.3K249,301Jan 28, 2026Jan 29, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
13,820$7.62$105.3K250,996Jan 27, 2026Jan 29, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
400,000——400,000Jan 13, 2026Jan 15, 2026 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
21,664$7.29$157.9K313,631Oct 28, 2025Oct 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
18,380$3.68$67.6K335,295Jul 29, 2025Jul 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,701$3.74$6.4K353,675Jul 28, 2025Jul 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
12,943$3.00$38.8K355,376Apr 30, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,558$3.23$11.5K368,319Apr 29, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
981$3.17$3.1K371,877Apr 28, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,709$3.17$5.4K372,858Apr 28, 2025Apr 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
298$2.84$846379,133Mar 27, 2025Mar 31, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,566$2.84$13.0K374,567Mar 27, 2025Mar 31, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
20,791$4.42$91.9K379,431Jan 30, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,109$4.55$9.6K400,222Jan 29, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
139,141——402,331Jan 28, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,283$4.63$10.6K263,190Jan 28, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
33,753$4.63$156.3K265,473Jan 28, 2025Jan 30, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
275,000——275,000Jan 10, 2025Jan 14, 2025 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
299$4.38$1.3K303,792Dec 27, 2024Dec 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,566$4.42$20.2K299,226Dec 27, 2024Dec 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,300$5.95$13.7K304,091Oct 29, 2024Oct 30, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,697$6.06$10.3K311,496Oct 28, 2024Oct 30, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,105$6.06$30.9K306,391Oct 28, 2024Oct 30, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
295$7.51$2.2K319,355Sep 27, 2024Oct 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,162$7.46$46.0K313,193Sep 27, 2024Oct 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,702$8.85$15.1K328,728Jul 29, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,078$8.51$77.3K319,650Jul 29, 2024Jul 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
295$6.26$1.8K339,508Jun 27, 2024Jul 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,078$6.24$56.6K330,430Jun 27, 2024Jul 1, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,695$6.38$10.8K339,803Apr 29, 2024Apr 29, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
348$7.70$2.7K341,498Mar 27, 2024Mar 29, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,005$9.64$19.3K341,846Jan 29, 2024Jan 31, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
200,000——343,851Jan 16, 2024Jan 18, 2024 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
294$11.51$3.4K143,851Dec 27, 2023Dec 29, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,697$6.03$10.2K144,145Oct 30, 2023Nov 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
294$8.38$2.5K145,842Sep 27, 2023Sep 29, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,693$11.80$20.0K146,136Jul 28, 2023Jul 31, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
294$12.12$3.6K147,829Jun 27, 2023Jun 28, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
863$11.16$9.6K149,272Apr 28, 2023May 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
2,012$11.16$22.5K148,123Apr 28, 2023Jun 1, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
347$15.36$5.3K150,135Mar 27, 2023Mar 28, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
864$21.56$18.6K150,482Jan 30, 2023Jan 31, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
101,115——151,346Jan 17, 2023Jan 19, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
104,600——104,600Jan 17, 2023Jan 19, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
97,630——97,630Jan 17, 2023Jan 19, 2023 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
445$14.49$6.4K50,231Dec 27, 2022Dec 28, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
1,099$21.54$23.7K50,676Oct 28, 2022Nov 1, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
443$22.73$10.1K51,775Sep 27, 2022Sep 29, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
26,257$4.12$108.2K78,475Sep 8, 2022Sep 8, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
26,257——0Sep 8, 2022Sep 8, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
26,257$30.00$787.7K52,218Sep 8, 2022Sep 8, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
734$21.26$15.6K52,218Jul 28, 2022Jul 29, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
300$20.31$6.1K52,952Jun 27, 2022Jun 28, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
725$25.57$18.5K53,252Apr 28, 2022May 2, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
282$29.87$8.4K53,977Mar 29, 2022Mar 31, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Chief Financial Officer
13,286$4.12$54.7K67,545Mar 24, 2022Mar 28, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
13,286$30.00$398.6K54,259Mar 24, 2022Mar 28, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Chief Financial Officer
13,286——26,257Mar 24, 2022Mar 28, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
39,270——54,259Jan 27, 2022Jan 31, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,540——78,540Jan 27, 2022Jan 31, 2022 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
295$33.10$9.8K14,989Dec 27, 2021Dec 27, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500——39,543Nov 15, 2021Nov 16, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500$35.40$796.5K15,284Nov 15, 2021Nov 16, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
22,500$4.12$92.7K37,784Nov 15, 2021Nov 16, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
293$36.87$10.8K15,284Sep 27, 2021Sep 27, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500——62,043Sep 13, 2021Sep 13, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500$35.00$787.5K15,577Sep 13, 2021Sep 13, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
22,500$4.12$92.7K38,077Sep 13, 2021Sep 13, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
293$35.81$10.5K15,577Jun 28, 2021Jun 30, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
22,500$4.12$92.7K38,370Jun 7, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500$35.00$787.5K15,870Jun 7, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500——84,543Jun 7, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500$35.00$787.5K15,870Mar 30, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
22,500$4.12$92.7K38,370Mar 30, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500——107,043Mar 30, 2021Jun 9, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500$35.00$787.5K0Mar 30, 2021Apr 1, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
22,500——107,043Mar 30, 2021Apr 1, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
22,500$4.12$92.7K22,500Mar 30, 2021Apr 1, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,870——15,870Mar 26, 2021Mar 26, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
31,740——31,740Mar 26, 2021Mar 26, 2021 ↗View →
RLAY
RELAY THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
63,363——63,363Dec 11, 2020Dec 15, 2020 ↗View →
Other insiders · RLAY
Loading peer insiders…
About this filer
CIK 0001818261
ROLE
Chief Financial Officer
PRIMARY
RLAY
COMPANIES
1
ACTIVE SINCE
Dec 2020
MARKETPEEL · /INSIDER/0001818261DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback